Experiment: 6YI2

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	650 uM [U-13C; U-15N] UvrD CTD	90% H2O/10% D2O	70 mM	6.5	1 atm	310	Bruker AVANCE III 800
2	2D 1H-13C HSQC aliphatic	650 uM [U-13C; U-15N] UvrD CTD	90% H2O/10% D2O	70 mM	6.5	1 atm	310	Bruker AVANCE III 800
3	2D 1H-13C HSQC aromatic	650 uM [U-13C; U-15N] UvrD CTD	90% H2O/10% D2O	70 mM	6.5	1 atm	310	Bruker AVANCE III 800
4	3D CBCA(CO)NH	650 uM [U-13C; U-15N] UvrD CTD	90% H2O/10% D2O	70 mM	6.5	1 atm	310	Bruker AVANCE III 800
5	3D HNCACB	650 uM [U-13C; U-15N] UvrD CTD	90% H2O/10% D2O	70 mM	6.5	1 atm	310	Bruker AVANCE III 800
6	3D HNCA	650 uM [U-13C; U-15N] UvrD CTD	90% H2O/10% D2O	70 mM	6.5	1 atm	310	Bruker AVANCE III 800
7	3D HNCO	650 uM [U-13C; U-15N] UvrD CTD	90% H2O/10% D2O	70 mM	6.5	1 atm	310	Bruker AVANCE III 800
9	3D HCCH-TOCSY	650 uM [U-13C; U-15N] UvrD CTD	90% H2O/10% D2O	70 mM	6.5	1 atm	310	Bruker AVANCE III 700
8	3D 1H-15N NOESY	650 uM [U-13C; U-15N] UvrD CTD	90% H2O/10% D2O	70 mM	6.5	1 atm	310	Bruker AVANCE III 700
10	3D 1H-13C NOESY aliphatic	650 uM [U-13C; U-15N] UvrD CTD	90% H2O/10% D2O	70 mM	6.5	1 atm	310	Bruker AVANCE III 700
11	3D 1H-13C NOESY aromatic	650 uM [U-13C; U-15N] UvrD CTD	90% H2O/10% D2O	70 mM	6.5	1 atm	310	Bruker AVANCE III 700

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	700
2	Bruker	AVANCE III	800

NMR Refinement
Method	Details	Software
molecular dynamics		ARIA

NMR Ensemble Information
Conformer Selection Criteria	all calculated structures submitted
Conformers Calculated Total Number	10
Conformers Submitted Total Number	10
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	ARIA	2.3	Linge, O'Donoghue and Nilges
2	structure calculation	CYANA	3.98.12	Guntert, Mumenthaler and Wuthrich
3	chemical shift assignment	Sparky	1.413	Goddard

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.